Deferasirox effect on renal haemodynamic parameters in patients with transfusion‐dependent β thalassaemia

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|168|6|882-890

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.168, Iss.6, 2015-03, pp. : 882-890

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transfusion‐dependent thalassaemic patients with renal Fanconi syndrome due to deferasirox use

By  

NEPHROLOGY, Vol. 20, Iss. 12, 2015-12 ,pp. : 931-935

John Wiley & Sons Inc

Access to resources Recommend Favorite

Activity of cytochrome P450 1A2 in relation to hepatic iron accumulation in transfusion‐dependent β‐thalassaemia major patients

By  

VOX SANGUINIS, Vol. 108, Iss. 3, 2015-04 ,pp. : 268-273

John Wiley & Sons Inc

Access to resources Recommend Favorite

When to consider transfusion therapy for patients with non‐transfusion‐dependent thalassaemia

By  

VOX SANGUINIS, Vol. 108, Iss. 1, 2015-01 ,pp. : 1-10

John Wiley & Sons Inc

Access to resources Recommend Favorite

Defining serum ferritin thresholds to predict clinically relevant liver iron concentrations for guiding deferasirox therapy when MRI is unavailable in patients with non‐transfusion‐dependent thalassaemia

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 2, 2015-01 ,pp. : 284-290

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of Iron Chelation Therapy on Glucose Metabolism in Non-Transfusion-Dependent Thalassaemia

By  

Acta Haematologica, Vol. 137, Iss. 1, 2016-11 ,pp. : 20-26

Karger

Access to resources Recommend Favorite